Logo

People in the News: Apr 28, 2011

Apr 28, 2011
Premium

Arrowhead Research said that it has appointed City of Hope researcher John Rossi to the scientific advisory board of subsidiary Calando Pharmaceuticals.

Rossi is one of Calando's co-founders. He also co-founded RNAi firm Dicerna Pharmaceuticals, and is a member of the SABs of Benitec and Kylin Therapeutics.

Filed under

Gene Silencing/Gene Editing
RNAi
Calando
Arrowhead
Breaking News
The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.